Nephros (NASDAQ:NEPH – Get Free Report) is projected to release its earnings data before the market opens on Wednesday, March 5th. Analysts expect Nephros to post earnings of ($0.01) per share and revenue of $3.57 million for the quarter. Parties interested in registering for the company’s conference call can do so using this link.
Nephros Stock Down 6.6 %
Nephros stock opened at $1.41 on Tuesday. Nephros has a 52-week low of $1.36 and a 52-week high of $3.19. The firm’s fifty day moving average is $1.55 and its 200 day moving average is $1.60. The company has a market cap of $14.87 million, a price-to-earnings ratio of -15.67 and a beta of 1.19.
Wall Street Analyst Weigh In
Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $5.00 price target on shares of Nephros in a report on Tuesday, November 12th.
About Nephros
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Read More
- Five stocks we like better than Nephros
- What is Insider Trading? What You Can Learn from Insider Trading
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Short Selling: How to Short a Stock
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What Does Downgrade Mean in Investing?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.
